vs
Idaho Strategic Resources, Inc.（IDR）与STANDARD BIOTOOLS INC.（LAB）财务数据对比。点击上方公司名可切换其他公司
STANDARD BIOTOOLS INC.的季度营收约是Idaho Strategic Resources, Inc.的1.3倍（$19.6M vs $14.6M），Idaho Strategic Resources, Inc.净利率更高（64.3% vs -177.4%，领先241.7%），Idaho Strategic Resources, Inc.同比增速更快（92.0% vs -11.5%），Idaho Strategic Resources, Inc.自由现金流更多（$8.2M vs $-23.1M），过去两年Idaho Strategic Resources, Inc.的营收复合增速更高（57.2% vs -12.2%）
爱达荷战略资源公司是一家总部位于美国的自然资源企业，专注于关键战略矿产的勘探、开发与生产，主要在爱达荷州运营，产品覆盖稀土、金、银等品类，供应清洁能源、国防及工业制造等多个下游领域。
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
IDR vs LAB — 直观对比
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $14.6M | $19.6M |
| 净利润 | $9.4M | $-34.7M |
| 毛利率 | 68.5% | 48.5% |
| 营业利润率 | 62.4% | -168.5% |
| 净利率 | 64.3% | -177.4% |
| 营收同比 | 92.0% | -11.5% |
| 净利润同比 | 220.6% | -28.8% |
| 每股收益（稀释后） | $0.62 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $14.6M | — | ||
| Q3 25 | $11.1M | $19.6M | ||
| Q2 25 | $9.5M | $21.8M | ||
| Q1 25 | $7.3M | $40.8M | ||
| Q4 24 | $7.6M | — | ||
| Q3 24 | $6.2M | $22.1M | ||
| Q2 24 | $6.1M | $22.5M | ||
| Q1 24 | $5.9M | $45.5M |
| Q4 25 | $9.4M | — | ||
| Q3 25 | $3.0M | $-34.7M | ||
| Q2 25 | $2.8M | $-33.5M | ||
| Q1 25 | $1.6M | $-26.0M | ||
| Q4 24 | $2.9M | — | ||
| Q3 24 | $1.6M | $-26.9M | ||
| Q2 24 | $2.2M | $-45.7M | ||
| Q1 24 | $2.2M | $-32.2M |
| Q4 25 | 68.5% | — | ||
| Q3 25 | 63.6% | 48.5% | ||
| Q2 25 | 57.8% | 48.8% | ||
| Q1 25 | 50.8% | 48.4% | ||
| Q4 24 | 53.3% | — | ||
| Q3 24 | 48.7% | 54.9% | ||
| Q2 24 | 50.2% | 46.1% | ||
| Q1 24 | 48.1% | 53.1% |
| Q4 25 | 62.4% | — | ||
| Q3 25 | 23.4% | -168.5% | ||
| Q2 25 | 26.6% | -118.1% | ||
| Q1 25 | 19.3% | -80.8% | ||
| Q4 24 | 36.2% | — | ||
| Q3 24 | 23.4% | -120.9% | ||
| Q2 24 | 34.2% | -134.5% | ||
| Q1 24 | 36.3% | -132.2% |
| Q4 25 | 64.3% | — | ||
| Q3 25 | 26.8% | -177.4% | ||
| Q2 25 | 29.2% | -153.7% | ||
| Q1 25 | 22.1% | -63.8% | ||
| Q4 24 | 38.5% | — | ||
| Q3 24 | 25.8% | -122.0% | ||
| Q2 24 | 35.2% | -203.3% | ||
| Q1 24 | 36.8% | -70.6% |
| Q4 25 | $0.62 | — | ||
| Q3 25 | $0.20 | $-0.09 | ||
| Q2 25 | $0.20 | $-0.09 | ||
| Q1 25 | $0.12 | $-0.07 | ||
| Q4 24 | $0.21 | — | ||
| Q3 24 | $0.12 | $-0.07 | ||
| Q2 24 | $0.17 | $-0.12 | ||
| Q1 24 | $0.17 | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $129.4M |
| 总债务越低越好 | $2.3M | — |
| 股东权益账面价值 | $108.2M | $399.7M |
| 总资产 | $116.2M | $539.6M |
| 负债/权益比越低杠杆越低 | 0.02× | — |
8季度趋势，按日历期对齐
| Q4 25 | — | — | ||
| Q3 25 | — | $129.4M | ||
| Q2 25 | — | $158.6M | ||
| Q1 25 | — | $150.9M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $210.6M | ||
| Q2 24 | $6.3M | $269.8M | ||
| Q1 24 | $5.3M | $287.1M |
| Q4 25 | $2.3M | — | ||
| Q3 25 | $3.0M | — | ||
| Q2 25 | $3.3M | — | ||
| Q1 25 | $3.7M | — | ||
| Q4 24 | $1.7M | — | ||
| Q3 24 | $2.9M | $55.2M | ||
| Q2 24 | $2.7M | $55.1M | ||
| Q1 24 | $3.3M | $55.0M |
| Q4 25 | $108.2M | — | ||
| Q3 25 | $74.3M | $399.7M | ||
| Q2 25 | $49.3M | $424.5M | ||
| Q1 25 | $39.8M | $454.6M | ||
| Q4 24 | $37.7M | — | ||
| Q3 24 | $33.1M | $489.3M | ||
| Q2 24 | $25.4M | $510.3M | ||
| Q1 24 | $21.6M | $577.3M |
| Q4 25 | $116.2M | — | ||
| Q3 25 | $83.1M | $539.6M | ||
| Q2 25 | $57.7M | $557.0M | ||
| Q1 25 | $48.1M | $579.6M | ||
| Q4 24 | $44.0M | — | ||
| Q3 24 | $40.8M | $681.5M | ||
| Q2 24 | $32.2M | $708.7M | ||
| Q1 24 | $28.7M | $777.7M |
| Q4 25 | 0.02× | — | ||
| Q3 25 | 0.04× | — | ||
| Q2 25 | 0.07× | — | ||
| Q1 25 | 0.09× | — | ||
| Q4 24 | 0.05× | — | ||
| Q3 24 | 0.09× | 0.11× | ||
| Q2 24 | 0.11× | 0.11× | ||
| Q1 24 | 0.15× | 0.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $10.7M | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | $8.2M | $-23.1M |
| 自由现金流率自由现金流/营收 | 56.0% | -118.1% |
| 资本支出强度资本支出/营收 | 17.7% | 4.5% |
| 现金转化率经营现金流/净利润 | 1.15× | — |
| 过去12个月自由现金流最近4个季度 | $12.4M | $-111.1M |
8季度趋势，按日历期对齐
| Q4 25 | $10.7M | — | ||
| Q3 25 | $2.4M | $-22.2M | ||
| Q2 25 | $3.5M | $-20.7M | ||
| Q1 25 | $2.4M | $-30.3M | ||
| Q4 24 | $3.2M | — | ||
| Q3 24 | $2.5M | $-27.9M | ||
| Q2 24 | $2.6M | $-39.0M | ||
| Q1 24 | $2.6M | $-62.5M |
| Q4 25 | $8.2M | — | ||
| Q3 25 | $709.8K | $-23.1M | ||
| Q2 25 | $2.5M | $-22.6M | ||
| Q1 25 | $1.0M | $-35.3M | ||
| Q4 24 | $2.1M | — | ||
| Q3 24 | $1.9M | $-30.1M | ||
| Q2 24 | $2.4M | $-41.0M | ||
| Q1 24 | $2.3M | $-63.3M |
| Q4 25 | 56.0% | — | ||
| Q3 25 | 6.4% | -118.1% | ||
| Q2 25 | 26.5% | -103.6% | ||
| Q1 25 | 13.8% | -86.6% | ||
| Q4 24 | 28.0% | — | ||
| Q3 24 | 30.4% | -136.4% | ||
| Q2 24 | 38.7% | -182.2% | ||
| Q1 24 | 38.3% | -138.9% |
| Q4 25 | 17.7% | — | ||
| Q3 25 | 15.3% | 4.5% | ||
| Q2 25 | 10.8% | 8.7% | ||
| Q1 25 | 19.4% | 12.4% | ||
| Q4 24 | 13.6% | — | ||
| Q3 24 | 9.8% | 10.2% | ||
| Q2 24 | 4.3% | 8.6% | ||
| Q1 24 | 5.5% | 1.7% |
| Q4 25 | 1.15× | — | ||
| Q3 25 | 0.81× | — | ||
| Q2 25 | 1.28× | — | ||
| Q1 25 | 1.50× | — | ||
| Q4 24 | 1.08× | — | ||
| Q3 24 | 1.56× | — | ||
| Q2 24 | 1.22× | — | ||
| Q1 24 | 1.19× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IDR
暂无分部数据
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
